Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorthamber Regulatory News (NAR)

Share Price Information for Northamber (NAR)

Share Price is delayed by 15 minutes
Get Live Data
26.00    0.00 (0.00%)
Bid:
24.00
Ask:
28.00
Spread: 4.00 (16.667%)
Market Cap: £7.05m
NAR Live PriceLast checked at - London Stock Exchange

Intraday Northamber Share Chart

Interim Management Statement

15 May 2013 07:00

RNS Number : 7153E
Northamber PLC
15 May 2013
 



Northamber plc

("Northamber" or the "Company")

Interim Management Statement

 

The continued strong decline in demand for PC's during the first quarter of 2013 has been well publicised and confirms our statements on trading made over a number of recent years. This trend and, more specifically the accompanying price and margin erosion, show no signs of abating. Several major vendors have quantified the effects on their business; IBM is reportedly negotiating the exit of its "X Series" server market via a sale to Chinese I.T. giant Lenovo, with Siemens having terminated its investment and I.T. sector partnership with Fujitsu a few years ago.

 

The search for new products and our own exit from some mature major PC & Server franchises has not held us harmless and it will be no surprise that the reducing turnover trends previously reported, have continued; for our three quarters ended 31st March 2013, turnover was some 20% lower than for the comparative period last year. This was, however, a slightly better result than achieved for the half year to December 2012 where turnover was 22% lower than the previous comparative period.

 

We continued our policy, adopted some time ago, of seeking ranges of products more pertinent to current customer demands and higher margins. The industry wide pressure on prices and profits was to some extent, therefore, neutralised and our operating gross margin was very slightly increased for the 9 months to end of Q3 when compared with the relative same period last year.

 

Such a major and ongoing reduction in turnover and its dilution of overhead costs inevitably causes difficulties in maintaining overall profitability. The continual need to restructure costs and align operations with revenue takes time and with it significant additional staff restructuring.

 

We have kept our usual careful oversight on costs, being wary not to decimate the business whilst mindful of the need to invest and develop alternative strategies, which cater to the shift in user expectations . Significant cost savings have been and are being implemented and operating expenses have fallen by 14% for the 9 months to 31st March, compared with the previous year. That is after taking account of some exceptional very significant redundancy and related costs. Nevertheless, despite cost savings, the inevitable result was an operating loss for the 9 month period which exceeded that made in the comparative period last year.

 

We continue to drive necessary changes in moving from high volume, very low margin solutions and the policy of seeking higher margins and products that better meet the commercial needs of our customers own businesses. Steps are being taken to accelerate this movement, however it will take some time for the impact to be fully realised.

 

Whilst the update on our trading position is not comforting and a turnaround will not be immediate, the outlook is not all gloom. There are opportunities available which we shall endeavour to maximise over the shortest time feasible.

 

The very considerable core strength of our totally tangible asset base, including annual formula depreciation, is such that we are not restricted in being able to effect change.

 

We remain both cash positive with zero debt or borrowings, with our net current assets ratio still within the highly acceptable range of 2.7 to 3.0 despite the pressure from both customers and suppliers to extend debtor days and decrease creditor days. Our Net Assets per share of 82.7 pence (as at 31 March 2013) are more than 2.5 times the current market value of our shares (based on the closing mid market price as at 14 May 2013 of 30.5 pence).

 

The Board strives to maximise returns for shareholders and continues to review all potential courses of action in that regard.

 

15 May 2013

 

For further information please contact:

 

Northamber plc 020 8296 7000

David Phillips / John Henry

 

Charles Stanley Securities 020 7149 6942

Philip Davies

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSNKQDKABKDAPD
Date   Source Headline
26th Nov 202112:07 pmRNSPosting of Annual Report
19th Nov 20217:00 amRNSFinal Results
6th Apr 20217:00 amRNSBoard Appointments
10th Mar 202112:31 pmRNSResult of AGM
22nd Feb 20212:06 pmRNSSecond Price Monitoring Extn
22nd Feb 20212:00 pmRNSPrice Monitoring Extension
12th Feb 20217:00 amRNSHalf-year Report
11th Feb 20216:27 pmRNSAnnual Financial Report - Amendment
11th Feb 20215:17 pmRNSAnnual Financial Report
10th Feb 202111:14 amRNSTransfer of Shares to Director
29th Jan 20215:05 pmRNSFinal Results
22nd Dec 20202:30 pmRNSUpdate on Annual Report and Trading
28th Oct 20207:00 amRNSAppointment of Chairman
13th Oct 202012:29 pmRNSHolding(s) in Company
13th Oct 202012:27 pmRNSHolding(s) in Company
27th Aug 20207:00 amRNSAppointment of Managing Director
3rd Aug 20207:00 amRNSChange of Adviser
14th May 20209:00 amRNSChange of Auditor
11th May 20209:32 amRNSHolding(s) in Company
19th Mar 20205:02 pmRNSHolding(s) in Company
4th Mar 20205:00 pmRNSTransaction in Own Shares
3rd Mar 20207:00 amRNSHalf-year Report
11th Feb 20202:49 pmRNSHolding(s) in Company
6th Feb 20203:50 pmRNSReplacement: Board change
6th Feb 20203:00 pmRNSBoard change
3rd Feb 20207:00 amRNSCompletion of AVM Acquisition
18th Dec 20192:00 pmRNSPotential Acquisition
18th Dec 20191:15 pmRNSResult of AGM
13th Dec 201911:00 amRNSPurchase of Warehouse Facility
5th Dec 20195:00 pmRNSStatement regarding David Phillips
25th Nov 201910:00 amRNSAnnual Financial Report
14th Nov 20197:00 amRNSFinal Results
1st Jul 20194:44 pmRNSSecond Price Monitoring Extn
1st Jul 20194:38 pmRNSPrice Monitoring Extension
1st Jul 20192:00 pmRNSSale of Warehouse Facility for £16.4 million
8th Mar 20197:00 amRNSHalf-year Report
27th Feb 20197:00 amRNSDirectorate Change
14th Dec 20182:15 pmRNSResult of AGM
30th Nov 20181:04 pmRNSTransaction in Own Shares
14th Nov 20187:00 amRNSPosting of Annual Report
20th Sep 20187:00 amRNSFinal Results
17th Aug 20183:23 pmRNSTransaction in Own Shares
25th May 201811:10 amRNSHolding(s) in Company
17th May 201812:44 pmRNSHolding(s) in Company
14th Feb 20187:00 amRNSHalf-year Report
12th Dec 20174:18 pmRNSResult of AGM
17th Nov 201710:12 amRNSAnnual Financial Report
3rd Nov 20177:00 amRNSFinal Results
27th Mar 20177:00 amRNSHalf-year Report
18th Nov 20168:30 amRNSPosting of Annual Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.